Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate

Abstract.: Naftidrofuryl is a peripheral vasodilator that has been clinically used in the treatment of intermittent claudication and dementia. It has 5-hydroxytryptamine 2 (5-HT2) antiserotonergic activity and selectively binds with the 5-HT2 receptor. The purpose of the present study is to assess t...

Full description

Bibliographic Details
Main Authors: Saida Abdel Regal Aly, Murad Hossain, Mohiuddin Ahmed Bhuiyan, Takashi Nakamura, Takafumi Nagatomo
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S134786131931151X
_version_ 1828413640365047808
author Saida Abdel Regal Aly
Murad Hossain
Mohiuddin Ahmed Bhuiyan
Takashi Nakamura
Takafumi Nagatomo
author_facet Saida Abdel Regal Aly
Murad Hossain
Mohiuddin Ahmed Bhuiyan
Takashi Nakamura
Takafumi Nagatomo
author_sort Saida Abdel Regal Aly
collection DOAJ
description Abstract.: Naftidrofuryl is a peripheral vasodilator that has been clinically used in the treatment of intermittent claudication and dementia. It has 5-hydroxytryptamine 2 (5-HT2) antiserotonergic activity and selectively binds with the 5-HT2 receptor. The purpose of the present study is to assess the binding affinity and functional potency of naftidrofuryl to the 5-HT2A receptor, to find out the inverse agonist activity of this compound at a constitutively active mutant of 5-HT2A receptor, and finally to compare the findings with those of sarpogrelate. The investigation showed that the binding affinity (pKi) of naftidrofuryl was decreased 25- or 50-fold compared to sarpogrelate in the wild-type 5-HT2A receptor or Cys322Lys mutant receptor, respectively. Moreover, the functional potency (pKb) of naftidrofuryl was much lower compared to sarpogrelate at the 5-HT2A receptor. In addition, inverse agonist activity of naftidrofuryl was lower compared with sarpogrelate at the constitutively active mutant receptor. Thus, the data of the present study would be very important for the clarification of interaction sites of naftidrofuryl to 5-HT2A receptors and also may help to understand the mechanism of inverse agonist activity at the constitutively active mutant receptor. Keywords:: naftidrofuryl, inverse agonist activity, constitutively active mutant, sarpogrelate
first_indexed 2024-12-10T13:12:32Z
format Article
id doaj.art-f472e63f0f6c46c7be0d6b6cc29ed535
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-10T13:12:32Z
publishDate 2009-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-f472e63f0f6c46c7be0d6b6cc29ed5352022-12-22T01:47:38ZengElsevierJournal of Pharmacological Sciences1347-86132009-01-011104445450Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of SarpogrelateSaida Abdel Regal Aly0Murad Hossain1Mohiuddin Ahmed Bhuiyan2Takashi Nakamura3Takafumi Nagatomo4Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, Japan; Corresponding author. nagatomot@s4.dion.ne.jpAbstract.: Naftidrofuryl is a peripheral vasodilator that has been clinically used in the treatment of intermittent claudication and dementia. It has 5-hydroxytryptamine 2 (5-HT2) antiserotonergic activity and selectively binds with the 5-HT2 receptor. The purpose of the present study is to assess the binding affinity and functional potency of naftidrofuryl to the 5-HT2A receptor, to find out the inverse agonist activity of this compound at a constitutively active mutant of 5-HT2A receptor, and finally to compare the findings with those of sarpogrelate. The investigation showed that the binding affinity (pKi) of naftidrofuryl was decreased 25- or 50-fold compared to sarpogrelate in the wild-type 5-HT2A receptor or Cys322Lys mutant receptor, respectively. Moreover, the functional potency (pKb) of naftidrofuryl was much lower compared to sarpogrelate at the 5-HT2A receptor. In addition, inverse agonist activity of naftidrofuryl was lower compared with sarpogrelate at the constitutively active mutant receptor. Thus, the data of the present study would be very important for the clarification of interaction sites of naftidrofuryl to 5-HT2A receptors and also may help to understand the mechanism of inverse agonist activity at the constitutively active mutant receptor. Keywords:: naftidrofuryl, inverse agonist activity, constitutively active mutant, sarpogrelatehttp://www.sciencedirect.com/science/article/pii/S134786131931151X
spellingShingle Saida Abdel Regal Aly
Murad Hossain
Mohiuddin Ahmed Bhuiyan
Takashi Nakamura
Takafumi Nagatomo
Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
Journal of Pharmacological Sciences
title Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
title_full Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
title_fullStr Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
title_full_unstemmed Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
title_short Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
title_sort assessment of binding affinity to 5 hydroxytryptamine 2a 5 ht2a receptor and inverse agonist activity of naftidrofuryl comparison with those of sarpogrelate
url http://www.sciencedirect.com/science/article/pii/S134786131931151X
work_keys_str_mv AT saidaabdelregalaly assessmentofbindingaffinityto5hydroxytryptamine2a5ht2areceptorandinverseagonistactivityofnaftidrofurylcomparisonwiththoseofsarpogrelate
AT muradhossain assessmentofbindingaffinityto5hydroxytryptamine2a5ht2areceptorandinverseagonistactivityofnaftidrofurylcomparisonwiththoseofsarpogrelate
AT mohiuddinahmedbhuiyan assessmentofbindingaffinityto5hydroxytryptamine2a5ht2areceptorandinverseagonistactivityofnaftidrofurylcomparisonwiththoseofsarpogrelate
AT takashinakamura assessmentofbindingaffinityto5hydroxytryptamine2a5ht2areceptorandinverseagonistactivityofnaftidrofurylcomparisonwiththoseofsarpogrelate
AT takafuminagatomo assessmentofbindingaffinityto5hydroxytryptamine2a5ht2areceptorandinverseagonistactivityofnaftidrofurylcomparisonwiththoseofsarpogrelate